---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000826"
form_type: "8-K"
ticker: "ACTU"
cik: "0001652935"
company_name: "ACTUATE THERAPEUTICS, INC."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:56:05.944534+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Actuate Therapeutics sets first annual meeting for May 22, 2025; deadlines announced

## Summary
- First Annual Meeting of Stockholders will be held virtually on May 22, 2025.
- Record date for voting entitlement is March 25, 2025.
- Rule 14a-8 stockholder proposals must be received by February 21, 2025, for proxy inclusion.
- Advance notice for director nominations and other proposals also due by February 21, 2025.

## SEC filing metadata
- accession: 0001683168-25-000826
- form_type: 8-K
- ticker: ACTU
- cik: 0001652935
- company_name: ACTUATE THERAPEUTICS, INC.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652935/000168316825000826/0001683168-25-000826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652935/000168316825000826/actuate_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000826
- JSON: https://secwatch.observer/filing/0001683168-25-000826.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000826.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.